By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update EB05 Selected for U.S. Government Funded Study in ARDS In June 2024, Edesa Biotech, Inc. (NASDAQ:EDSA) announced ...

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Phase 3 ARDS Study Expanded to Include Mechanically Ventilated Patients In May 2022, Edesa Biotech, Inc. (NASDAQ ...

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its ...

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Readying IND for EB06 in Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti ...

A high-level overview of Edesa Biotech, Inc. (EDSA) stock. View (EDSA) real-time stock price, chart, news, analysis, analyst reviews and more.